FDA Logo--links to FDA home page
U.S. Food and Drug Administration
HHS Logo--links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizontal rule

Recall -- Firm Press Release

FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

Perrigo Company Announces Nationwide Recall of Infants' Oral Drops Containing Enclosed Syringe

Contact:
Ernest J. Schenk
(269) 673-9212

FOR IMMEDIATE RELEASE -- Allegan, MI -- July 29, 2005 -- The Perrigo Company (Nasdaq: PRGO; TASE) is voluntarily recalling all lots of concentrated infants’ drops that are packaged with a dosing syringe bearing only a “1.6 mL” mark containing:

  1. acetaminophen,
  2. acetaminophen, dextromethorphan HBr, and pseudoephedrine HCl, or
  3. dextromethorphan HBr, and pseudoephedrine HCl.

The dosing syringe may be confusing in determining the proper dose for infants under 2 years of age as directed by a doctor and could lead to improper dosing, including overdosing. The following products are being recalled to the retail level:

The directions on the bottle and carton labeling for infants ages 2-3 years and weighing 24-35 pounds allow safe and effective dosing for this age and weight group. However, these products are also intended for use by infants younger than 2 years and weighing less than 24 pounds. The labeling directs consumers to ask a doctor for dosing directions for this age and weight group.

The products are being recalled because the oral dosing syringe enclosed with these products is not marked so as to accurately measure doses less than 1.6 mL when prescribed by physicians for infants younger than 2 years and weighing less than 24 pounds. Until recently these products were provided with a dropper, not the oral dosing syringe, and the dropper had two markings on it (“0.4 mL” and “0.8 mL”). The single mark on the current syringe along with the changeover from the dropper to this syringe has caused some confusion among consumers and health-care professionals and may lead to improper dosing. Taking more than the recommended dose (overdose) of acetaminophen may cause liver damage. The products, however, are safe and effective when accurately dosed. Parents or caregivers who have questions should discuss with their doctor how to accurately determine the proper dose.

The recalled products were sold nationally at retail chains under the following store-brand labels: American Fare, Best Choice, Brooks, Berkley & Jensen, CVS, Dollar General, Eckerd, Equaline, Equate, Family Dollar, Food Lion, Good Neighbor, GoodSense, Healthy Generations, Health Pride, Hy-Vee, Kroger, Leader, Longs, Major, Medicine Shoppe, Meijer, Parklane, Publix, Rite Aid, Safeway, Shop Rite, Sunmark, Target, Today’s Health, Top Care, Walgreen, Western Family, and Winn Dixie.

Perrigo is cooperating with the U.S. Food and Drug Administration (the “FDA”) in this recall and in the effort to alert consumers and retailers about this issue. Questions or concerns about a product described in this recall should be directed to Perrigo’s Consumer Affairs Department, toll free, at 800-321-0105. Any adverse reactions experienced with the use of these products should also be reported to the FDA’s MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-1078, by mail at MedWatch, HF-410, FDA, 5600 Fishers Lane , Rockville , MD 20852-9787, or on MedWatch’s website at https://www.accessdata.fda.gov/scripts/medwatch/.

####

Related FDA Talk Paper (Aug. 1, 2005)

RSS Feed for FDA Recalls Information [what's this?]

rule Get free e-mail alerts about Class I recalls rule